VISTAGEN THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of -1.37% for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2026-06-15
- VISTAGEN THERAPEUTICS, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2026 was -1.37%.
- VISTAGEN THERAPEUTICS, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2025 was -0.29%.
- VISTAGEN THERAPEUTICS, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2024 was -0.49%, a 139.52% decline from fiscal 2023.
- VISTAGEN THERAPEUTICS, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2023 was 1.24%.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month as first filed |
|---|---|---|
| 2026-03-31 | -1.37% 10-K · filed 2026-06-15 | |
| 2025-03-31 | -0.29% 10-K · filed 2026-06-15 | -0.60% 10-K · filed 2025-06-17 |
| 2024-03-31 | -0.49% 10-K · filed 2025-06-17 | 0.49% 10-K · filed 2024-06-11 |
| 2023-03-31 | 1.24% 10-K · filed 2024-06-11 | |
| 2022-03-31 | 0.00% 10-K · filed 2023-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |